stockrowAgios Pharmaceuticals, Inc. (AGIO) vs Nurix Therapeutics, Inc. (NRIX)
- Agios Pharmaceuticals, Inc. AGIO 29.41 +4.03%
- Nurix Therapeutics, Inc. NRIX 15.30 +3.10%
Agios Pharmaceuticals, Inc. and Nurix Therapeutics, Inc. are both Biotechnology companies. Agios Pharmaceuticals, Inc. and Nurix Therapeutics, Inc. are of similar size ($1.7B and $1.6B). Agios Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; Nurix Therapeutics, Inc. trades at 6.1×. Nurix Therapeutics, Inc. grew revenue faster over the last twelve months: 738.8% against 214.4%. Nurix Therapeutics, Inc. has the higher net margin (42.0% vs −264.8%) and the higher return on invested capital (0.00% vs −75.0%). Across the 17 metrics below, Nurix Therapeutics, Inc. leads on 15 and Agios Pharmaceuticals, Inc. on 2.
Valuation
Profitability
| Metric | AGIO | NRIX | Biotechnology median |
|---|---|---|---|
| Gross margin | 93.81% | 100.00% | 68.51% |
| Operating margin | (297.72%) | 41.27% | 0.00% |
| Net margin | (264.76%) | 42.01% | 0.00% |
| Free cash flow margin | (238.54%) | 52.68% | 0.00% |
| Return on equity | (32.95%) | 43.99% | (51.96%) |
| Return on assets | (30.44%) | 34.33% | (46.06%) |
| Return on invested capital | (75.02%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack